Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics in neonates with gastrointestinal surgery
NCT03266315Terminated
- Sponsor
- University of Calgary
- Start
- Dec 2022
- Primary completion
- Jul 2024
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial of FloraBaby in dysbiosis, sponsored by University of Calgary. Primary endpoint: Diversity and abundance of stool microbiome at 3 weeks. Started Dec 2022; status: terminated.
02
Drugs
FloraBaby
03
Conditions
dysbiosis
Beyond the preview
Go deeper on NCT03266315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03266315.